These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29459625)

  • 21. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
    Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
    Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The coarse-grained plaque: a divergent Aβ plaque-type in early-onset Alzheimer's disease.
    Boon BDC; Bulk M; Jonker AJ; Morrema THJ; van den Berg E; Popovic M; Walter J; Kumar S; van der Lee SJ; Holstege H; Zhu X; Van Nostrand WE; Natté R; van der Weerd L; Bouwman FH; van de Berg WDJ; Rozemuller AJM; Hoozemans JJM
    Acta Neuropathol; 2020 Dec; 140(6):811-830. PubMed ID: 32926214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APP mutations in the Aβ coding region are associated with abundant cerebral deposition of Aβ38.
    Moro ML; Giaccone G; Lombardi R; Indaco A; Uggetti A; Morbin M; Saccucci S; Di Fede G; Catania M; Walsh DM; Demarchi A; Rozemuller A; Bogdanovic N; Bugiani O; Ghetti B; Tagliavini F
    Acta Neuropathol; 2012 Dec; 124(6):809-21. PubMed ID: 23143229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Transmission of pathogenic protein aggregates in Alzheimer's disease].
    Schwarzman AL; Sarantseva SV
    Mol Biol (Mosk); 2017; 51(3):418-422. PubMed ID: 28707657
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Jean L; Brimijoin S; Vaux DJ
    J Biol Chem; 2019 Apr; 294(16):6253-6272. PubMed ID: 30787102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.
    Kumar-Singh S
    Int J Mol Sci; 2009 Apr; 10(4):1872-1895. PubMed ID: 19468344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Cerebral Amyloid Angiopathy in Two Transgenic Mouse Models of Cerebral β-Amyloidosis: A Neuropathological Study.
    Marazuela P; Paez-Montserrat B; Bonaterra-Pastra A; Solé M; Hernández-Guillamon M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studies.
    Kurz C; Walker L; Rauchmann BS; Perneczky R
    Neuropathol Appl Neurobiol; 2022 Apr; 48(3):e12782. PubMed ID: 34823269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
    Gkanatsiou E; Portelius E; Toomey CE; Blennow K; Zetterberg H; Lashley T; Brinkmalm G
    Neurosci Lett; 2019 May; 701():125-131. PubMed ID: 30807796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
    Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
    J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyroglutamate-3 amyloid-β deposition in the brains of humans, non-human primates, canines, and Alzheimer disease-like transgenic mouse models.
    Frost JL; Le KX; Cynis H; Ekpo E; Kleinschmidt M; Palmour RM; Ervin FR; Snigdha S; Cotman CW; Saido TC; Vassar RJ; St George-Hyslop P; Ikezu T; Schilling S; Demuth HU; Lemere CA
    Am J Pathol; 2013 Aug; 183(2):369-81. PubMed ID: 23747948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous Aβ seeds induce Aβ depositions in the blood vessels rather than the brain parenchyma, independently of Aβ strain-specific information.
    Hamaguchi T; Kim JH; Hasegawa A; Goto R; Sakai K; Ono K; Itoh Y; Yamada M
    Acta Neuropathol Commun; 2021 Sep; 9(1):151. PubMed ID: 34507620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains.
    Hérard AS; Petit F; Gary C; Guillermier M; Boluda S; Garin CM; ; Lam S; Dhenain M
    Acta Neuropathol Commun; 2020 Nov; 8(1):205. PubMed ID: 33250056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
    Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
    J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The length of amyloid-beta in hereditary cerebral hemorrhage with amyloidosis, Dutch type. Implications for the role of amyloid-beta 1-42 in Alzheimer's disease.
    Castaño EM; Prelli F; Soto C; Beavis R; Matsubara E; Shoji M; Frangione B
    J Biol Chem; 1996 Dec; 271(50):32185-91. PubMed ID: 8943274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis.
    Eisele YS; Obermüller U; Heilbronner G; Baumann F; Kaeser SA; Wolburg H; Walker LC; Staufenbiel M; Heikenwalder M; Jucker M
    Science; 2010 Nov; 330(6006):980-2. PubMed ID: 20966215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood-derived amyloid-β protein induces Alzheimer's disease pathologies.
    Bu XL; Xiang Y; Jin WS; Wang J; Shen LL; Huang ZL; Zhang K; Liu YH; Zeng F; Liu JH; Sun HL; Zhuang ZQ; Chen SH; Yao XQ; Giunta B; Shan YC; Tan J; Chen XW; Dong ZF; Zhou HD; Zhou XF; Song W; Wang YJ
    Mol Psychiatry; 2018 Sep; 23(9):1948-1956. PubMed ID: 29086767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.